This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Raskind, W. H. Articles by Reid, B. J. Search for Related Content PubMed PubMed Citation Articles by Raskind, W. H. Articles by Reid, B. J.

Persistent Clonal Areas and Clonal Expansion in Barrett's Esophagus¹

Departments of Medicine [W. H. R., D. S. L., R. C. H., B. J. R.] and Pathology [T. N., R. C. H., P. S. R.], University of Washington School of Medicine, Seattle, Washington 98195

Three patients with Barrett's esophagus who had cytogenetic abnormalities detected in their metaplastic epithelium developed high-grade dysplasia or adenocarcinoma during prospective surveillance over a period of 1.5 to 6 years. In the 3 cases, cytogenetic abnormalities that were associated with the most advanced histological lesions were present in samples obtained 11, 25, and 48 months prior to the diagnosis of high-grade dysplasia or carcinoma. In a fourth patient, marker chromosomes found in a Barrett's adenocarcinoma were also present in an esophageal region spatially removed from the tumor. In all four patients, clonal cytogenetic abnormalities were present in samples obtained at widespread locations in the Barrett's segment. These observations suggest that in some patients with Barrett's esophagus clonal proliferations arise in regions of benign histology and spread to involve large areas of Barrett's mucosa. These clones persisted when the disease progressed to high-grade dysplasia or adenocarcinoma.

¹ This work was supported by NIH Grant P01 DK32971 and Grant PDT316B from the American Cancer Society.

² To whom requests for reprints should be addressed, at Department of Medicine RG20, University of Washington, Seattle, WA 98195.

Received 12/10/91. Accepted 3/ 1/92.

This article has been cited by other articles:

				E. Pohler, A. L. Craig, J. Cotton, L. Lawrie, J. F. Dillon, P. Ross, N. Kernohan, and T. R. Hupp The Barrett's Antigen Anterior Gradient-2 Silences the p53 Transcriptional Response to DNA Damage Mol. Cell. Proteomics, June 1, 2004; 3(6): 534 - 547. [Abstract] [Full Text] [PDF]

				D. T. McManus, A. Olaru, and S. J. Meltzer Biomarkers of Esophageal Adenocarcinoma and Barrett's Esophagus Cancer Res., March 1, 2004; 64(5): 1561 - 1569. [Abstract] [Full Text] [PDF]

				P. K. Ha and J. A. Califano THE MOLECULAR BIOLOGY OF MUCOSAL FIELD CANCERIZATION OF THE HEAD AND NECK Crit. Rev. Oral. Biol. Med., September 1, 2003; 14(5): 363 - 369. [Abstract] [Full Text] [PDF]

				J. A. Jankowski, N. A. Wright, S. J. Meltzer, G. Triadafilopoulos, K. Geboes, A. G. Casson, D. Kerr, and L. S. Young Molecular Evolution of the Metaplasia-Dysplasia-Adenocarcinoma Sequence in the Esophagus Am. J. Pathol., April 1, 1999; 154(4): 965 - 973. [Abstract] [Full Text] [PDF]

				P. M. Schneider, A. G. Casson, B. Levin, H. S. Garewal, A. H. Hoelscher, K. Becker, H.-J. Dittler, K. R. Cleary, M. Troster, J. Ruediger Siewert, et al. MUTATIONS OF p53 IN BARRETT'S ESOPHAGUS AND BARRETT'S CANCER: A PROSPECTIVE STUDY OF NINETY-EIGHT CASES J. Thorac. Cardiovasc. Surg., February 1, 1996; 111(2): 323 - 333. [Abstract] [Full Text]

				S. Cross, C. Sanchez, C. Morgan, M. Schimke, S Ramel, R. Idzerda, W. Raskind, and B. Reid A p53-dependent mouse spindle checkpoint Science, March 3, 1995; 267(5202): 1353 - 1356. [Abstract] [PDF]